Skip to main content
Clinical Trials/ISRCTN48755084
ISRCTN48755084
Completed
Phase 3

A randomised controlled trial of the effectiveness of excisional surgery versus imiquimod 5% cream for long-term clinical success rate in patients with nodular and superficial basal cell carcinoma

niversity of Nottingham (UK)0 sites501 target enrollmentMarch 31, 2010

Overview

Phase
Phase 3
Intervention
Not specified
Conditions
Not specified
Sponsor
niversity of Nottingham (UK)
Enrollment
501
Status
Completed
Last Updated
7 years ago

Overview

Brief Summary

Registry
who.int
Start Date
March 31, 2010
End Date
April 23, 2010
Last Updated
7 years ago
Study Type
Interventional
Sex
All

Investigators

Sponsor
niversity of Nottingham (UK)

Eligibility Criteria

Inclusion Criteria

  • 1\. Primary nodular or superficial basal cell carcinoma located in low risk area
  • 2\. Access to telephone
  • 3\. Histologically proven BCC
  • Male or female participants of any age were recruited.

Exclusion Criteria

  • 1\. Genetic or nevoid conditions e.g., Gorlin's syndrome
  • 2\. Morphoeic (microinfiltrative) as diagnosed clinically
  • 3\. Allergy to any of the interventions
  • 4\. Involvement in a trial of another experimental intervention
  • 5\. Life threatening disease
  • 6\. Bleeding disorders
  • 7\. Unavailable for 3 years follow\-up
  • 8\. Pregnant or breastfeeding

Outcomes

Primary Outcomes

Not specified

Similar Trials